Please login or register first to view this content.
Immune Disorders Resource Center
Drug Monographs
Click on the subsection below to see prescribing information
NEWS & FEATURES
Newly Diagnosed Lupus Erythematosus Could Potentially Be Drug Induced
Inolimomab BLA Submitted for Graft Versus Host Disease
Voclosporin Granted Priority Review for Lupus Nephritis
Avacopan NDA Submitted for ANCA-Associated Vasculitis
Trial Investigating Ustekinumab for Systemic Lupus Erythematosus Discontinued
Tacrolimus Inhalation Powder Gets Orphan Drug Status for Organ Rejection Prophylaxis
Long-Term Rituximab May Aid in Antibody-Associated Vasculitis
FDA Grants Orphan Drug Status to Antifibrotic Therapy for Systemic Sclerosis
Voclosporin NDA for Lupus Nephritis Submitted to FDA
Trial Evaluating Ruxolitinib for COVID-19 Associated Cytokine Storm Initiated
Telitacicept Fast-Tracked for Systemic Lupus Erythematosus
Patient’s Death Leads to Lawsuit After Physician Fails to Check Creatinine Level Before Infusing Drug
Remestemcel-L Under Review for Steroid-Refractory Acute Graft Versus Host Disease
FDA: Insulin Among Drugs Transitioned to Biological Products
Certain Blister Packages of Sandimmune, Neoral Not Child Resistant
The FDA Approval Process Needs Refinement, Not a Total Overhaul
Anifrolumab Improves Response at 52 Weeks in Lupus
Belimumab Associated With Meaningful Improvement in Lupus Nephritis Trial
